Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BMP Pharma Trading AGSTU:BMP 36 Shareholder Yield % is 8.20% as of Dec. 2025, which is 11% below its 10-year median of 9.23. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 115 Medical Distribution companies, BMP Pharma Trading AG ranks better than 73.04% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, BMP Pharma Trading AG's Shareholder Yield % was 8.20%.
BMP Pharma Trading AG (STU:BMP) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
BMP Pharma Trading AG Shareholder Yield % Related Terms
BMP Pharma Trading AG Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for BMP Pharma Trading AG's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:BMP vs MCK, COR, CAH: Shareholder Yield % Comparison
For the Medical Distribution subindustry, BMP Pharma Trading AG's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BMP Pharma Trading AG Shareholder Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where BMP Pharma Trading AG's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
BMP Pharma Trading AG (STU:BMP) has a Shareholder Yield % of 8.20% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on BMP Pharma Trading AG and its competitors. This is 11% below median its historical median of 9.23. Over the past decade, BMP Pharma Trading AG's Shareholder Yield % has ranged from 3.17 to 20.91. According to the industry distribution chart, BMP Pharma Trading AG ranks #31 out of 115 companies in the Medical Distribution industry, placing it in the top 27%.
Is BMP Pharma Trading AG's Shareholder Yield % too high?
BMP Pharma Trading AG's current Shareholder Yield % of 8.20% is 11% below median its 10-year median of 9.23. Over the past 10 years, this metric has ranged from a low of 3.17 to a high of 20.91. The Medical Distribution industry median Shareholder Yield % is 2.37. BMP Pharma Trading AG's value of 8.20% is 246% above this industry median. Based on the distribution chart, BMP Pharma Trading AG ranks #31 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's Shareholder Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, BMP Pharma Trading AG ranks #31 out of 115 companies for Shareholder Yield %. This puts BMP Pharma Trading AG in the upper half of its industry. The industry median Shareholder Yield % is 2.37. BMP Pharma Trading AG's value of 8.20% is 246% above this benchmark. Historically, BMP Pharma Trading AG's own Shareholder Yield % has ranged from 3.17 to 20.91 over the past decade. While the company's 10-year median is 9.23 vs. the industry median of 2.37, BMP Pharma Trading AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Distribution company?
The median Shareholder Yield % among Medical Distribution companies is 2.37, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BMP Pharma Trading AG's current Shareholder Yield % of 8.20% is 246% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on BMP Pharma Trading AG and its competitors. For the Medical Distribution industry, the median Shareholder Yield % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BMP Pharma Trading AG's current Shareholder Yield % is 8.20%, which is 11% below median its own 10-year median of 9.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current Shareholder Yield % of 8.20%. The current Shareholder Yield % is 8.20%, which is 11% below median its 10-year median of 9.23 and 246% above the Medical Distribution industry median of 2.37. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current Shareholder Yield % is 8.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score
Get the complete analysis for STU:BMP
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BMP has been successfully added to your 
